Drugs / Hypromellose Eye Drop
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT04541888 Background | Nov 2020 → Aug 2021 | dry eye syndrome | Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hypromellose Eye Drop | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04541888 ↗ |